Tailoring neoadjuvant chemotherapy for a pregnant patient diagnosed with IB2 squamous cervical carcinoma
Status PubMed-not-MEDLINE Jazyk angličtina Země Nizozemsko Médium electronic-ecollection
Typ dokumentu kazuistiky, časopisecké články
PubMed
39498418
PubMed Central
PMC11532939
DOI
10.1016/j.gore.2024.101532
PII: S2352-5789(24)00211-X
Knihovny.cz E-zdroje
- Klíčová slova
- Cervical cancer, Individualized therapy, Neoadjuvant chemotherapy, Pregnancy,
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
The incidence of cancer during pregnancy is steadily rising because of the postponement of plans for childbearing. One of the most common cancers diagnosed during pregnancy is cervical cancer. Diagnosis of most cases usually occurs in the early stages, but there are still cases of tumors staged IB2 and higher. In these cases, the treatment strategy entails administration of neoadjuvant chemotherapy. However, a universally recognized standardized regimen for neoadjuvant chemotherapy treatment of cervical cancer during pregnancy has yet to be established. The chemotherapy agents used during treatment are known for their fetal adverse effects. The aim of the therapy is to attain full-term pregnancy while minimizing fetal toxicity and decreasing tumor size. In this case report, we present a first-time sequential chemotherapy administration to minimize the cumulative toxicity of individual regimens and demonstrate the benefits for the patient and fetus.
Zobrazit více v PubMed
Al-Saleh E., Al-Harmi J., Nandakumaran M., Al-Shammari M. Transport kinetics of cisplatin in the perfused human placental lobule in vitro. J Matern Fetal Neonatal Med. 2008 Oct;21(10):726–731. PubMed
Amant F., Berveiller P., Boere I.A., Cardonick E., Fruscio R., Fumagalli M., et al. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. Ann Oncol. 2019 Oct 1;30(10):1601–1612. PubMed
Babkova A., Rob L., Kubecova M., Hruda M., Halaska M.J. Middle cerebral artery peak systolic velocity monitoring of fetal anemia during chemotherapy in pregnancy. Acta Obstet Gynecol Scand. 2024 Apr;103(4):660–668. PubMed PMC
Barr JJ, Mari G. Cerebral Blood Flow Velocity Waveforms and Fetal Anemia. In: Maulik D, Lees CC, editors. Doppler Ultrasound in Obstetrics and Gynecology [Internet]. Cham: Springer International Publishing; 2023 [cited 2024 Jan 7]. p. 297–311. Available from: https://doi.org/10.1007/978-3-031-06189-9_18.
Bernardini F., Ferrandina G., Ricci C., Fagotti A., Fanfani F., Cavaliere A.F., et al. Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study. Curr Oncol. 2022 Aug 14;29(8):5702–5714. PubMed PMC
Cintra GF, Derchain SFM, Bicalho DS, Filho AL da S, Primo WQSP. Cervical cancer in pregnancy. Rev Bras Ginecol Obstet [Internet]. 2023 Jun 20 [cited 2024 Aug 19];45(5):293–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281765/. PubMed PMC
Clemens E, van den Heuvel-Eibrink MM, Mulder RL, Kremer LCM, Hudson MM, Skinner R, et al. Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium. Lancet Oncol [Internet]. 2019 Jan [cited 2023 Dec 26];20(1):e29–41. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549756/. PubMed PMC
de Haan J., Verheecke M., Van Calsteren K., Van Calster B., Shmakov R.G., Mhallem Gziri M., et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018 Mar;19(3):337–346. PubMed
Eibye S., Kjær S.K., Mellemkjær L. Incidence of pregnancy-associated cancer in Denmark, 1977–2006. Obstet Gynecol. 2013 Sep;122(3):608–617. PubMed
Gangireddy M, Nookala V. Ifosfamide. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Dec 26]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK542169/.
Geijteman ECT, Wensveen CWM, Duvekot JJ, van Zuylen L. A child with severe hearing loss associated with maternal cisplatin treatment during pregnancy. Obstet Gynecol. 2014 Aug;124(2 Pt 2 Suppl 1):454–6. PubMed
Halaska M.J., Komar M., Vlk R., Tomek V., Skultety J., Robova H., et al. A pilot study on peak systolic velocity monitoring of fetal anemia after administration of chemotherapy during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2014 Mar;174:76–79. PubMed
Huang H., Quan Y., Qi X., Liu P. Neoadjuvant chemotherapy with paclitaxel plus cisplatin before radical surgery for locally advanced cervical cancer during pregnancy: A case series and literature review. Medicine (baltimore). 2021 Aug 13;100(32):e26845. PubMed PMC
Van Calsteren K. Chemotherapy during pregnancy: pharmacokinetics and impact on foetal neurological development. Facts Views vis Obgyn. 2010;2(4):278–286. PubMed PMC
Vandenbroucke T., Verheecke M., van Gerwen M., Van Calsteren K., Halaska M.J., Fumagalli M., et al. Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy. Eur J Cancer. 2020 Oct;138:57–67. PubMed PMC